Technical Analysis for NK - NantKwest, Inc.

Grade Last Price % Change Price Change
grade F 1.06 3.92% 0.04
NK closed up 3.92 percent on Friday, May 24, 2019, on 17 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical NK trend table...

Date Alert Name Type % Chg
Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
180 Bearish Setup Bearish Swing Setup 3.92%
Expansion Breakdown Bearish Swing Setup 3.92%
Reversal New Lows Setup Bearish Swing Setup 3.92%
BB Squeeze Ended Range Expansion 3.92%
Lower Bollinger Band Touch Weakness 3.92%
Oversold Stochastic Weakness 3.92%
Stochastic Buy Signal Bullish -3.64%

Older signals for NK ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

NantKwest, Inc., a biotechnology company, develops immunotherapeutic agents for various clinical conditions. It is initiating a Phase II clinical trial for its activated natural killer product candidate for the treatment of virally-induced cancers, such as polyomavirus induced Merkel cell carcinoma, human Papillomavirus, induced cervical cancer, and head and neck cancer, as well as infectious diseases comprising Ebola and other viral, fungal, and bacterial infections. The company also holds right to commercialize a range of genetically modified derivatives that kills cancer and virally infected cells. In addition, it focuses on to initiate a Phase I/II clinical trials for target activated natural killer product candidate for acute myeloid leukemia and bulky hematological cancers. The company was formerly known as Conkwest, Inc. and changed its name to NantKwest, Inc. in July 2015. NantKwest, Inc. was founded in 2002 and is headquartered in Cardiff-by-the-Sea, California.
Biotechnology Cancer Infectious Diseases Acute Myeloid Leukemia Infectious Causes Of Cancer Bacterial Infections Head And Neck Cancer Virus Human Papillomavirus Infection Carcinogenesis Cervical Cancer Ebola Merkel Cell Carcinoma Papillomavirus
Is NK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 4.23
52 Week Low 0.93
Average Volume 560,162
200-Day Moving Average 1.9237
50-Day Moving Average 1.2624
20-Day Moving Average 1.12
10-Day Moving Average 1.08
Average True Range 0.085
ADX 12.57
+DI 18.3263
-DI 21.2363
Chandelier Exit (Long, 3 ATRs ) 1.145
Chandelier Exit (Short, 3 ATRs ) 1.265
Upper Bollinger Band 1.2305
Lower Bollinger Band 1.0095
Percent B (%b) 0.23
BandWidth 19.732143
MACD Line -0.0507
MACD Signal Line -0.0491
MACD Histogram -0.0016
Fundamentals Value
Market Cap 84.21 Million
Num Shares 79.4 Million
EPS -1.29
Price-to-Earnings (P/E) Ratio -0.82
Price-to-Sales 7227.62
Price-to-Book 1.46
PEG Ratio 2.18
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.14
Resistance 3 (R3) 1.13 1.10 1.12
Resistance 2 (R2) 1.10 1.08 1.10 1.12
Resistance 1 (R1) 1.08 1.07 1.09 1.09 1.11
Pivot Point 1.05 1.05 1.06 1.05 1.05
Support 1 (S1) 1.03 1.03 1.04 1.04 1.01
Support 2 (S2) 1.00 1.02 1.00 1.00
Support 3 (S3) 0.98 1.00 1.00
Support 4 (S4) 0.99